Gait profile score as a summary index of gait pathology in freezing of gait and levodopa responses in Parkinson's disease.
Abstract
Background
Freezing of gait (FoG) is a disabling manifestation of Parkinson's disease (PD). Most gait studies in FoG rely on spatiotemporal parameters or discrete kinematic peaks, which may underestimate multi-joint deviations across the gait cycle. The Gait Profile Score (GPS) and Gait Variable Score (GVS) were introduced as composite indices to provide a more comprehensive and accessible evaluation. This study aimed to use GPS and GVS to detect gait differences between individuals with and without FoG (nFoG) and to assess the modulatory effects of levodopa (L-DOPA) medication.
Methods
Twenty-two individuals with PD (11 FoG) and 18 age-matched healthy controls were recruited. Kinematic data were collected during self-selected walking speed. PD participants were evaluated in both ON and OFF medication. GPS and GVS values were normalized using control data. A Linear Mixed-Effects Models (LMM) with Bonferroni correction was used to assess differences between groups (FoG and nFoG) and medication states (ON and OFF).
Findings
A significant group-by-medication interaction was observed for pelvic tilt and rotation, and ankle dorsiflexion, with FoG individuals exhibiting higher values in the OFF state. FoG group exhibited significantly higher GPS and GVS values mainly in the sagittal plane, compared with the nFoG group. L-DOPA medication was associated with reduced pelvic tilt, hip adduction, hip flexion, and ankle dorsiflexion.
Interpretation
GPS and GVS offer a concise description of FoG-related gait impairment, capturing distributed multi-joint deviations not evident from spatiotemporal parameters alone. The limited dopaminergic responsiveness of these indices highlights the contribution of non-dopaminergic mechanisms. These indices may serve as rapid, reliable tools for clinical and research applications in gait assessment.